SUMMARY Fifty eight patients (aged 8-59 years, mean 27) treated for prosthetic valve endocarditis from January 1966 to January 1985 were studied retrospectively by review of case notes. There were 12 cases of early and 46 cases of late prosthetic valve endocarditis. These developed in 28 patients with an isolated aortic valve, in 26 with an isolated mitral valve, and in four with both aortic and mitral prosthetic valves. Streptococci were the most commonly isolated microorganisms, followed by staphylococci, Gram negative bacteria, and fungi. A surgical (34 cases) or a necropsy specimen (10 cases) from 44 cases was examined. Eighty two per cent of the patients had congestive heart failure. Twenty four of the 58 patients were medically treated and 17 died (70% mortality). Combined medical and surgical treatment was used in 34 patients; the main indication for surgery was congestive heart failure. Fourteen patients on combined treatment died (40% mortality). Persistent sepsis and prosthetic valve dehiscence were the most common early and late operative complications. The most important influences on outcome were congestive heart failure, the type of micro-organism, the severity and extent of anatomical lesions, the time of onset of prosthetic valve endocarditis, and the type of treatment. This survey indicates that only patients without congestive heart failure or embolic complications and with sensitive micro-organism should be treated medically. In view of the poor prognosis patients with prosthetic valve endocarditis associated with congestive heart failure, persistent sepsis, and repeat -arterial emboli should be treated by early surgical intervention.
Despite advances in antimicrobial treatment Table 1 shows the micro-organisms that caused prosthetic valve endocarditis in this study. These were identified by blood cultures from 34 (59%) patients. Streptococci were the most commonly isolated organism, followed by staphylococci, Gram negative bacteria, and fungi. Twenty four (41%) patients had negative blood cultures. Streptococci were more common in late prosthetic valve endocarditis, whereas more antibiotic resistant microorganisms (staphylococci, Gram negative bacteria) were more common in early prosthetic valve endocarditis. Table 2 shows the likely sources of infection in 36 (62%) patients. Portals of entry were different in early and late prosthetic valve endocarditis; in late prosthetic valve endocarditis dental treatment (usually without antibiotic prophylaxis) was the most common factor indentified, followed by genital and urinary tract infection. Infections causing early prosthetic valve endocarditis occurred mainly during cardiopulmonary bypass or in the early postoperative period (11/12 cases Post-cardiopulmonary bypass Mortality from early prosthetic valve endocarditis was much higher (11/11) Like other workers,6 10-3 we too found that streptococci were the most common causal microorganisms-followed by staphylococci, Gram negative bacteria, and fungi. Streptococci commonly cause late prosthetic valve endocarditis, often after treatment, whereas staphylococci, Gram negative bacteria, and Candida species are more important in early prosthetic valve endocarditis.3 61 The organisms are mainly acquired in the operating rooms or in the intensive care unit.
There are differences in pathological findings between mechanical valves and bioprosthetic valves. In mechanical valves endocarditis is often associated with an infection behind the site of attachment of the prosthesis, resulting in ring abscess and dehiscence of the prosthesis.'5 Extension of infection to adjacent cardiac structures is very common and it may cause a myocardial abscess, disruption of the atrioventricular conduction system, or fistulas into the right heart or pericardium.'5 Vegetations are also common and they can be extensive, particularly in fungal infection. Ferrans et al found that bioprosthetic infection is usually localised to the cusps. '6 Renal failure and nephrotic syndrome are rare,'7 and due to a focal or diffuse glomerlonephritis and associated with immune complex in the serum and immunoglobulin deposits on the capillary wall. '8 Mortality from prosthetic valve endocarditis is high, ranging from 35% to 71%.'1 3-11-13 A new or an increased regurgitant murmur and the presence of congestive heart failure46 are associated with a very high mortality. We found 95% mortality in patients with heart failure compared with 50% in patients without congestive heart failure. The Extension of infection into the valve seat and adjacent tissues may result in partial or complete valve dehiscence, myocardial abscess, disruption of the atrioventricular conduction system, or fistulas into the right heart or pericardium. Our results and those of others6 19 20 suggest that invasion of the myocardium is associated with an increased mortality.
Mortality also varies with the time of onset of prosthetic valve endocarditis; most reports emphasise that prognosis is better in late prosthetic valve endocarditis6 101213 28 (e) The appearance of new murmurs caused by fistulas into the right heart or pericardium or by septal rupture. 26 
Conclusion
The high mortality in prosthetic valve endocarditis is mainly the result of congestive heart failure which is usually caused by prosthetic valve dysfunction. Mortality in early and late prosthetic valve endocarditis is reduced by prompt surgical intervention and adequate antibiotic treatment.
